182 related articles for article (PubMed ID: 1425936)
1. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Codd EE; Shank RP
Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
[TBL] [Abstract][Full Text] [Related]
2. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
3. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
4. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
5. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC
Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
[TBL] [Abstract][Full Text] [Related]
6. Oocytes from Xenopus laevis contain an intrinsic sigma 2-like binding site.
Patterson TA; Connor M; Appleyard SM; Chavkin C
Neurosci Lett; 1994 Oct; 180(2):159-62. PubMed ID: 7700571
[TBL] [Abstract][Full Text] [Related]
7. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
[TBL] [Abstract][Full Text] [Related]
8. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain.
Connor MA; Chavkin C
Mol Pharmacol; 1992 Sep; 42(3):471-9. PubMed ID: 1406599
[TBL] [Abstract][Full Text] [Related]
9. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
10. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
Bailey MA; Karbon EW
Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
[TBL] [Abstract][Full Text] [Related]
12. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
Harada Y; Hara H; Sukamoto T
Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
[TBL] [Abstract][Full Text] [Related]
14. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin.
DeHaven-Hudkins DL; Ford-Rice FY; Allen JT; Hudkins RL
Life Sci; 1993; 53(1):41-8. PubMed ID: 8515681
[TBL] [Abstract][Full Text] [Related]
16. Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa.
Harada Y; Hara H; Sukamoto T
J Pharmacol Exp Ther; 1994 Jun; 269(3):905-10. PubMed ID: 8014877
[TBL] [Abstract][Full Text] [Related]
17. [3H](+)-pentazocine binding to rat brain sigma 1 receptors.
Cagnotto A; Bastone A; Mennini T
Eur J Pharmacol; 1994 Jan; 266(2):131-8. PubMed ID: 8157067
[TBL] [Abstract][Full Text] [Related]
18. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of [3H]1,3-di-o-tolylguanidine binding sites with low affinity for haloperidol in rat brain.
Enomoto R; Ogita K; Yoneda Y
Biol Pharm Bull; 1993 Oct; 16(10):989-96. PubMed ID: 8287051
[TBL] [Abstract][Full Text] [Related]
20. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
Dumont M; Lemaire S
Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]